+++Шпрингер-3

[абр]

Помогите со статьями, пожалуйста!

1. 99mTcO(MAG2-3G3-dimer): a new integrin αvβ3-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics
Jiyun Shi1, 2, Lijun Wang1, Young-Seung Kim1, Shizhen Zhai1, Bing Jia2, Fan Wang2 and Shuang Li
European Journal of Nuclear Medicine and Molecular Imaging Volume 36, Number 11 / Ноябрь 2009 г. Страницы 1874-1884

Код: Выделить всё

http://dx.doi.org/10.1007/s00259-009-1166-1

2. Skeletal metastases: what is the future role for nuclear medicine?
Gary J. R. Cook
European Journal of Nuclear Medicine and Molecular Imaging Volume 36, Number 11 / Ноябрь 2009 г. Страницы 1803-1806

Код: Выделить всё

http://dx.doi.org/10.1007/s00259-009-1240-8

3. The influence of Bz-DOTA and CHX-A″-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules: implications for 114mIn-mediated targeting therapy
Vladimir Tolmachev, Helena Wållberg, Karl Andersson, Anders Wennborg, Hans Lundqvist and Anna Orlova
European Journal of Nuclear Medicine and Molecular Imaging Volume 36, Number 9 / Сентябрь 2009 г. Страницы 1460-1468

Код: Выделить всё

http://dx.doi.org/10.1007/s00259-009-1134-9

4. 68Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging
Zhaofei Liu, Gang Niu, Fan Wang and Xiaoyuan Chen
European Journal of Nuclear Medicine and Molecular Imaging Volume 36, Number 9 / Сентябрь 2009 г. Страницы 1483-1494

Код: Выделить всё

http://dx.doi.org/10.1007/s00259-009-1123-z

5. Monitoring cancer therapy with PET: probably effective, but more research is needed
Giovanni Lucignani
European Journal of Nuclear Medicine and Molecular Imaging Volume 36, Number 9 / Сентябрь 2009 г. Страницы 1520-1525

Код: Выделить всё

http://dx.doi.org/10.1007/s00259-009-1214-x

[Demcha]

[абр]

Спасибо!